Your session is about to expire
← Back to Search
Exercise for Anxiety Disorders
N/A
Recruiting
Led By Kristin Szuhany, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 visit
Summary
This trial will study whether exercise can help people with high levels of anxiety and anxiety disorders by improving their ability to learn and remember things.
Who is the study for?
This trial is for adults aged 18-60 with a primary diagnosis of an anxiety disorder (generalized, panic, or social) and high anxiety sensitivity. Participants must be able to exercise safely and not be pregnant, using benzodiazepines, or have recent substance abuse issues. Stable psychiatric medication use for at least 4 weeks prior is required.
What is being tested?
The study compares the effects of physical activity versus sitting on fear learning in people with high anxiety sensitivity and disorders. It looks into how these activities affect their expectations, emotions, and stress responses after learning to overcome fear.
What are the potential side effects?
Since this trial involves exercise as an intervention, potential side effects may include typical risks associated with physical activity such as muscle strain or injury. Sitting has minimal risk but may involve discomfort from remaining stationary.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 2 visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Heart rate (HR)
Skin Conductance Response (SCR)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise GroupExperimental Treatment1 Intervention
Participants who will be randomized to moderate intensity exercise after extinction (Day 1)
Group II: Seated groupPlacebo Group1 Intervention
Participants who will be randomized to sitting after extinction (Day 1)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~820
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,538 Total Patients Enrolled
Kristin Szuhany, MDPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have current PTSD but had it more than 6 months ago.I have been diagnosed with Bipolar Disorder or psychosis.I use benzodiazepines.You have a high level of anxiety sensitivity, as shown by a score of 23 or higher on the Anxiety Sensitivity Index-3.I have been diagnosed with an anxiety disorder like GAD, panic, or social anxiety.My psychiatric medications have been stable for at least 4 weeks.I am between 18 and 60 years old.I have been diagnosed with an anxiety disorder like GAD, panic, or social anxiety.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise Group
- Group 2: Seated group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger